JPRN-UMIN000004936已完成2 期
Palonosetron+Aprepitant+Dexamethasone for moderately emetic chemotherapy induced nausea and voimiting-Phase II study- - Palonosetron+Aprepitant+Dexamethasone for moderately emetic chemotherapy induced nausea and voimiting
iigata Lung Cancer Treatment Group0 个研究点目标入组 160 人开始时间: 2011年1月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)MEC administration except Day 1. 2)Radiation therapy 3)Contraindication of Dexamethasone 4)Symptomatic brain meta 5)Hypersensitivity for Palonosetron, Aprepitant, Dexamethasone 6)Vomiting episode prior to chemotherapy with 24 hours
研究者
相似试验
已完成
2 期
Palonosetron+Aprepitant+Dexamethasone for highly emetic chemotherapy induced nausea and voimitingJPRN-UMIN000004865iigata Lung Cancer Treatment Group95
招募中
2 期
Palonosetoron+Aprepitant+Dexamethasone Therapy in patients receiving moderately emetogenic anticancer drugs (EJCG-1001)ung cancerJPRN-UMIN000006498East Japan Chesters Group (EJCG)90
招募中
不适用
Aprepitant, Palonosetron and Dexamethasone Antiemetic Therapy Evaluation trial in germ cell tumor (APDATE)Germ cell tumorJPRN-UMIN000008110Department of Urology, Sapporo Medical University School of Medicine30
已完成
2 期
Study of Aprepitant / Palonosetron / Dexamethasone for nausea and vomiting induced chemotherapy for breast cancer.Breast cancerJPRN-UMIN000004025Saitama Breast Cancer Clinical Study Group(SBCCSG)55
尚未招募
2 期
A clinical trial to compare two different drug schedules used for prevention of post-operative nausea and vomiting in patients undergoing total abdominal hysterectomyCTRI/2023/08/056041Prashant Dhatwalia